Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00925561 · ClinicalTrials.gov registry record
Examining the Genetic Predictors of Coronary Artery Calcification in African Americans
A clinical trial of Atherosclerosis, sponsored by University of Michigan.
- Completed
- Registry status
- 752
- Enrollment target
- 1
- Study location
NCT00925561 is a study of Atherosclerosis that has completed, run by University of Michigan. The registered enrollment target is 752 participants, below the 1,055-participant average among 69 other Atherosclerosis trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00925561, a study of Atherosclerosis, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 752 participants
- Enrollment target
- 1
- Study location
Study Summary
Coronary artery disease (CAD) is an important health concern for African Americans, who are diagnosed with CAD at high rates. Coronary artery calcification, which is characterized by calcium deposits in the coronary arteries, is a contributing factor to CAD. This study will examine the possible genetic causes of coronary artery calcification in African Americans.
Conditions Studied
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 752 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00925561
The ClinicalTrials.gov registry entry for NCT00925561 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 752 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,055-participant average among 69 other Atherosclerosis trials with a reported enrollment target (29% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atherosclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT00925561 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.
Frequently Asked Questions
What is clinical trial NCT00925561 about?
NCT00925561 is a clinical study titled "Examining the Genetic Predictors of Coronary Artery Calcification in African Americans". Coronary artery disease (CAD) is an important health concern for African Americans, who are diagnosed with CAD at high rates. Coronary artery calcification, which is characterized by calcium deposits in the coronary arteries, is a contributing factor to CAD. This study will examine the possible gene...
What is the current status of trial NCT00925561?
This trial is currently completed. The enrollment target is 752 participants. The study started on 2009-01. Estimated completion is 2013-04.
What conditions does trial NCT00925561 study?
This clinical trial studies the following conditions: Atherosclerosis.
Who is sponsoring clinical trial NCT00925561?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00925561 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
RECRUITING · Phase 4
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
-
Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.